Induced sputum: Opening a new window to the lung

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 18, Issue 3, 2001, Pages 263-271

  Fireman, E ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Induced sputum; Lung diseases

Indexed keywords

SODIUM CHLORIDE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERSTITIAL LUNG DISEASE; LUNG CANCER; OCCUPATIONAL LUNG DISEASE; PNEUMOCONIOSIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SARCOIDOSIS; SPUTUM ANALYSIS; SPUTUM SMEAR;

ASTHMA; BRONCHOSCOPY; HUMANS; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; LYMPHOCYTE SUBSETS; PNEUMONIA, PNEUMOCYSTIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 0034828722     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects
2. Comparison of leukocyte counts in sputum, bronchial biopsies and bronchoalveolar lavage
3. Cellular profiles in asthmatic airways: A comparison of induced sputum, bronchial washings and bronchoalveolar lavage fluid
4. Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: Inflammatory cells, lymphocyte subsets and soluble markers compared
5. Leukocyte counts and macrophage phenotype in induced sputum and bronchoalveolar lavage fluid from normal subjects
6. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD
7. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma
8. Induced sputum cell counts in healthy adults
9. Induced sputum cellularity: References values distribution in normal volunteers
10. The evaluation of a cell dispersion method of sputum examination
11. Methods of examining induced sputum: Do differences matter?
12. Induced sputum examination
13. Comparison of two methods of processing induced sputum: Selected vs entire sputum
14. Update on sputum methodology
15. Validation of assays for inflammatory mediators in sputum
16. Induced sputum for the investigation of airway inflammation: Evidence for its clinical application
17. Induced sputum cell counts: Their usefulness in clinical practice
18. Clinical judgement of airway inflammation versus sputum cell counts in patients with asthma
19. Use of induced sputum cell counts to investigate airway inflammation in asthma
20. Comparison of two methods of processing induced sputum: Selected versus entire sputum
21. Some technical factors influencing the induction of sputum for cell analysis
22. Safety of one method of sputum induction in asthmatic subjects
23. Safety of inducing sputum in patients with asthma of varying severity
24. Comparison of spontaneous and induced sputum for the investigation of airway inflammation in chronic obstructive pulmonary disease
25. Prednisone dependent asthma: Inflammatory indices in induced
26. Sputum in severe exacerbations of asthma: Kinetics of inflammatory indices after prednisone treatment
27. Effect of sputum induction on spirometric measurements and arterial oxygen saturation in asthmatic patients, smokers and healthy subjects
28. Induced sputum cell and fluid phase indices of inflammation comparison of treatment with DTT vs PBS
29. The effect of processing on inflammatory markers in induced sputum
30. DTT has a dose response on cell surface antigen expression
31. Flow cytometric analysis of the effect of DTT on leukocyte surface markers
32. Between observer repeatability of sputum differential cell counts influence of cell viability and squamous cell contamination
33. Respiratory tract fluids: Analysis of content and contemporary use in understanding lung diseases
34. Bronchoalveolar lavage: A window of the lung
35. Bronchoalveolar lavage in asthma. An update and perspective
36. International consensus report on diagnosis and management of asthma
37. Human airway macrophages. A technique for the retrieval and a descriptive comparison with alveolar macrophages
38. Reassessment of inflammation of airways in chronic bronchitis
39. Indices of airway inflammation in induced sputum: Reproducibility and validity of cell and fluid measurements
40. Induced sputum: Validity of fluid-phase IL-5 measurement
41. Expression of exotoxin in induced sputum of atopic and non atopic asthmatics
42. Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics
43. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
44. House dust mite-specific IgE antibodies in induced sputum eosinophilia in mite-sensitive asthmatics
45. Exercise-induced bronchoconstriction does not cause eosinophilic airway inflammation or airway hyperresponsiveness in subjects with asthma
46. Eosinophils influx into the airways in patients with exercise induced bronchoconstriction
47. Eosinophil apoptosis in induced sputum from patients with seasonal allergic rhinitis and with asymptomatic and symptomatic asthma
48. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma
49. Effect of a 4-week treatment with theophylline on sputum eosinophilia and sputum eosinophil chemotactic activity in steroid naive asthmatics
50. Theophylline decreases sputum eosinophilia of asthmatics
51. Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum
52. Lymphocyte apoptosis in patients with acute exacerbation of asthma
53. Suppressive activity of bronchial macrophages recovered from induced sputum
54. Macrophage migration inhibitory factor (MIF) in bronchial asthma
55. Diagnosing occupational asthma: Use of induced sputum
56. Airway inflammation following exposure in diesel exhaust: A study of time kinetics using induced sputum
57. The cellular composition of induced sputum in chronic obstructive pulmonary diseases
58. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis
59. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: A randomized controlled trial
60. Serial sputum cell counts in the management of chronic airflow limitation
61. Airway inflammation and hyperresponsiveness to adenosine 5′ monophosphate in chronic obstructive pulmonary disease
62. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary diseases
63. A case for serial examination of sputum inflammatory cells
64. Induced sputum. Eosinophilic bronchitis and COPD
65. Non asthmatic chronic cough: No effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia
66. Sputum induction by newer inhalation method in patients with pulmonary tuberculosis
67. Sputum induction to improve the diagnostic yield in patients with suspected pulmonary tuberculosis
68. The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi
69. Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa
70. Usefulness of induced sputum analysis in pulmonary diseases
71. Comparison of induced sputum vs expectorated sputum for the diagnosis of pulmonary tuberculosis by acid-fast smear
72. Sputum induction for the diagnosis of Pneumocystis carinii pneumonia
73. Diagnosis of Pneumocystis carinii pneumonia: Immunofluorescence staining, simple PCR or nPCR
74. Development and evaluation of a rapid and simple procedure for detection of Pneumocystis carinii by PCR
75. Performance of a PCR assay for detection of Pneumocystis carinii from respiratory specimens
76. A comparison of induced and expectorate sputum for the microbiological diagnosis of community acquired pneumonia
77. An aerosol method of producing bronchial secretions in human subjects: A clinical technique for detection of lung cancer
78. Induced sputum and cytological diagnosis of lung cancer
79. The early detection of second primary lung cancers by sputum immunostaining
80. Evidence for the induction of a tumor associated cell surface protease on cytologically normal epithelial cells present in the sputum of patients possessing lung tumors
81. Advance in sputum analysis for screening and early detection of lung cancer
82. Comparison between smoking-related DNA adduct analysis in induced sputum and peripheral blood lymphocytes
83. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and non smokers
84. Immunoperoxidase detection of 4-aminobiphenyl and polycyclic aromatic hydrocarbons-DNA adducts in induced sputum of smokers and non smokers
85. Evaluation of occupational lung diseases by induced sputum compared to bronchoalveolar lavage
86. Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects
87. Bronchial dysplasia induced by radiation in miners exposed to 222Rn progeny
88. Relevance of asbestos bodies in sputum
89. Relationship between asbestos bodies in sputum and the number of specimens
90. Accelerated silicosis with mixed dust pneumoconiosis in a hard metal grinder
91. Evaluation of interstitial lung diseases by induced sputum compared to bronchoalveolar lavage
92. Induced sputum in patients with newly diagnosed sarcoidosis
93. Correlation of CD4/CD8 ratio and TNF α levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis
94. Sarcoidosis: From the pathologist's vantage point
95. Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity
96. Sarcoidosis: An organized pattern of reaction from immunology to therapy
97. Sarcoidosis
98. The motility of lung lymphocytes in hypersensitivity pneumonitis and sarcoidosis
99. Endobronchial biopsy positive sarcoidosis: Relation to bronchoalveolar lavage and course of disease
100. The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease
101. Lymphocyte dynamics in the pulmonary microenvironment: Implications for the pathophysiology of pulmonary sarcoidosis
102. Regional specialization in the mucosa immune system: Primed cells do not always home along the same track
103. The physiology of lymphocyte migration through the single lymph node in vivo
104. Diagnosing left ventricular dysfunction from induced sputum examination
105. Lipid laden macrophages in induced sputum are a marker of gastric oropharyngeal reflux and possible aspiration
106. Sputum induction in young cystic fibrosis patients
107. Induced sputum examination: Diagnosis of pulmonary involvement in Fabry's disease
108. Biological monitoring
109. Bronchoalveolar lavage cell population in the diagnosis of sarcoidosis
110. Sensitivity and specificity of BAL findings in sarcoidosis
111. CD4/CD8 ratios in bronchoalveolar lavage fluid: Of value for diagnosing sarcoidosis
112. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis
113. The prognostic and diagnostic value of T-lymphocyte subtypes analysis in idiopathic pulmonary fibrosis
114. Non invasive methods to measure airway inflammation: Future considerations